A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of CD34+ cells in NHL patients.

Partanen AnuAntti TurunenJaakko ValtolaKaija VasalaLasse ÅgrenKarri PenttiläMarja PyöräläTaru KuittinenPentti MäntymaaJukka PelkonenEsa JantunenVille Varmavuo

Published in: Journal of clinical apheresis (2020)

The mobilization of blood grafts with LIPEG added to chemotherapy was associated with higher CD34+ cell apheresis yields than with PEG. A randomized study is warranted to verify these findings.

Keyphrases

end stage renal disease
induced apoptosis
newly diagnosed
chronic kidney disease
prognostic factors
single cell
drug delivery
peritoneal dialysis
squamous cell carcinoma
nk cells
patient reported outcomes
stem cells
cell death
cell proliferation
rectal cancer
endoplasmic reticulum stress